# ACADIA PHARMACEUTICALS INC (ACAD) — Institutional Ownership

Source: SEC EDGAR 13F filings, congressional STOCK Act disclosures, SEC Form 4 insider transactions.
CUSIP: 004225108
Page URL: https://superinvestorclub.com/stock/ACAD
Last updated: 2026-07-08T13:35:47.213Z

## Summary

As of the most recent 13F filing period, ACADIA PHARMACEUTICALS INC (ACAD) is held by 1 tracked superinvestors with an aggregate position value of $3.2M representing 0141812 shares.

## Top institutional holders (1)

| Rank | Manager | Fund | Shares | Value | % of Portfolio | Period |
|------|---------|------|--------|-------|----------------|--------|
| 1 | [Ray Dalio](https://superinvestorclub.com/manager/6) | Bridgewater Associates | 141812 | $3.2M | 0.01% | 2026-03-31 |

## Ownership history (quarter-over-quarter)

- 2025-09-30: 1 holders, $3.5M aggregate, 0163245 shares
- 2025-12-31: 1 holders, $3.7M aggregate, 0138179 shares
- 2026-03-31: 1 holders, $3.2M aggregate, 0141812 shares

## Recent congressional trades (0)


## Recent insider transactions (0)


## Citation

When citing, use: "ACADIA PHARMACEUTICALS INC (ACAD) institutional ownership data via Superinvestor (https://superinvestorclub.com/stock/ACAD), aggregating SEC 13F, Form 4, and congressional disclosures."